Edition:
United States

Daiichi Sankyo Co Ltd (4568.T)

4568.T on Tokyo Stock Exchange

2,450JPY
26 Sep 2016
Change (% chg)

-- (--)
Prev Close
¥2,450
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,358,304
52-wk High
¥2,750
52-wk Low
¥1,972

4568.T

Chart for 4568.T

About

DAIICHI SANKYO COMPANY, LIMITED is a Japan-based holding company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the... (more)

Overall

Beta: 0.87
Market Cap(Mil.): ¥1,751,613.00
Shares Outstanding(Mil.): 709.01
Dividend: 35.00
Yield (%): 2.43

Financials

  4568.T Industry Sector
P/E (TTM): 21.80 36.61 36.60
EPS (TTM): 113.34 -- --
ROI: 4.91 14.46 13.91
ROE: 6.33 15.26 14.82

BRIEF-Daiichi Sankyo announces New Global Head of Development

* Daiichi Sankyo announces new global head of development Source text for Eikon: Further company coverage:

Sep 06 2016

BRIEF-Daiichi Sankyo plans 5th&6th series unsecured corporate bonds worth total 100 bln yen

* Says it plans to issue 5th series unsecured corporate bonds worth 75 billion yen, with coupon rate of 0.810 percent and maturity date on July 25, 2036

Jul 15 2016

BRIEF-Amgen and Daiichi Sankyo agree to commercialize Biosimilars in Japan

* Amgen and daiichi sankyo announce agreement to commercialize biosimilars in japan

Jul 13 2016

REFILE-UCB receives approval for epilepsy drug Vimpat in Japan

July 4 Belgian pharmaceutical company UCB said on Monday it received regulatory approval for its epilepsy drug Vimpat in Japan.

Jul 04 2016

BRIEF-Daiichi Sankyo says entered into agreement with Servier Canada

* Daiichi Sankyo Co Ltd says has entered into an agreement with Servier Canada

Jun 27 2016

BRIEF-Daiichi Sankyo plans 28 mln shares repurchase

* Says it plans to buy 28 million shares (4.1 percent outstanding) back, for up to 500 million yen, from June 21 to Oct. 28

Jun 20 2016

BRIEF-Daiichi Sankyo to buy back up to 50 bln yen of stock

* Daiichi Sankyo says to buy back up to 4.1 percent of own shares worth 50 billion yen ($480 million) Source text for Eikon: Further company coverage: ($1 = 104.5400 yen)

Jun 20 2016

BRIEF-Nitto signs partnership agreement with Daiichi Sankyo

* Signed a partnership agreement with Daiichi Sankyo company, ltd.

May 10 2016

Daiichi buys Japanese rights to UK heart stem cell therapy

LONDON A Welsh stem cell company founded by a Nobel prize winner has signed a partnership deal with Daiichi Sankyo, giving the drugmaker rights to develop its regenerative heart treatment for the Japanese market.

May 10 2016

Daiichi buys Japanese rights to UK heart stem cell therapy

LONDON, May 10 A Welsh stem cell company founded by a Nobel prize winner has signed a partnership deal with Daiichi Sankyo, giving the drugmaker rights to develop its regenerative heart treatment for the Japanese market.

May 10 2016

Earnings vs. Estimates